Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
Recruiting
Observational Study
Chemotherapy-induced Peripheral Neuropathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 188 (estimated)
- Sponsor
- University of Southern Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* Willing to give informed consent
* Scheduled to receive neo-adjuvant or adjuvant paclitaxel treatment
* Able to speak and understand Danish
* Diagnosed with breast cancer
* Paclitaxel naïve patients
Exclusion Criteria:
* Neurodegenerative diseases (e.g., ne…
Contacts